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Abstract 
Malaria is a deadly infection caused by a single celled protozoan of the Plasmodium 
genus. Plasmodium spp. are transmitted to humans by mosquitoes, and initially invade the 
liver, but the disease is caused by the blood stage of the infection. Approximately 500 million 
cases of malaria are documented annually and over 1 million of those result in death. 
Plasmodium falciparum is the most lethal of five species known to infect humans. To further 
compound this problem, drug-resistant parasite strains have been documented for every 
currently available antimalarial drug, making the need to identify new drug targets more 
urgent than ever. Modern genetics have found that more than 50% of the Plasmodium 
genome codes for proteins of unknown functions, with no significant sequence homology to 
any known eukaryotic genes. Recent advances in forward genetics and the use of 
transposable elements to manipulate the genome of P. falciparum have made tremendous 
contributions to discovering the functions of these unknown genes, which is critical to rapidly 
advance antimalarial drug development. 
In this study we have identified a gene of unknown function, PF3D7_1143500, that is 
significant for intraerythrocytic development of Plasmodium.  This gene exhibits weak 
similarities to the human regulator of chromatin condensation 1 protein (RCC1) and appears 
to belong to the class of RCC1-like proteins that perform diverse functions in eukaryotes.  A 
thorough cellular and molecular analysis of an insertional knockout mutant of 
PF3D7_1143500 in P. falciparum has revealed a critical role for this gene in the production 
of merozoites during the intraerythrocytic cycle. The insertional mutant parasite strain 
displays a significant delay in initiating nuclear division, which results in a 40% reduction in 
the number of merozoites produced at the end of the intraerythrocytic cycle, thereby severely 
attenuating the parasite growth rate.  PF3D7_1143500 localizes to the microtubule 
vii 
organization centers within the nucleus during the early stages of parasite development, 
suggesting it functions in regulating mitosis. Since cell cycle regulatory mechanisms are 
largely unknown in Plasmodium, the identification of this novel RCC1-like protein promises 
to offer new insights into this critical biological pathway that has high potential as an 
antimalarial drug target. 
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Introduction: 
Importance 
Malaria is a parasitic infection that has been causing disease in humans for thousands 
of years (Neghina et al. 2010). Malaria is widespread, pervasive, costly, and rapidly 
becoming resistant to modern drugs. There are 300-500 million cases of malaria reported 
annually, with more than 1 million of these cases resulting in death. Most cases of malaria 
occur in tropical regions, home to more than half of the world’s population. However, 
modern travel has allowed the disease to escape tropical regions. In 2009 there were more 
than 1400 cases in the United States (Mali et al. 2011). The majority of those infected in the 
United States acquired the disease following travel to endemic regions. Worldwide, malaria 
has a tremendous monetary cost. There is a substantial direct economic cost of running and 
stocking treatment facilities with effective drugs. The total direct monetary cost is estimated 
to be over 12 billion dollars annually according to the Center for Disease Control (CDC). The 
indirect cost on economic growth is believed to be several times that number. For example, 
many sick people are unable to work or are required to spend time with sick children in lieu 
of working. 
There are currently several anti-malarial drugs on the market but drug resistant strains 
of Plasmodium falciparum have been on the rise. The previous first line drug, chloroquine, 
has been compromised by the development of resistant strains.  Resistance is a result of the 
mutation of a protein pump that is now capable of transporting the drug out of the cytosol 
(Ecker et al. 2012). Multiple drug regimens have been established in order to combat the rise 
of antimalarial resistant strains. Drug regimens are specifically tailored to optimize 
effectiveness based on the prevalent resistant strains. The development of resistance has been 
determined to rise from communities where there is low transmission and high population 
density. The hosts in these areas provide selective conditions for the expansion of resistant 
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strains. Over time these conditions have led to the development of significant resistance to 
previously effective drug regimens (White and Pongtavornpinyo 2003). The newest 
antimalarial drugs have already encountered resistant strains, and it is the rise in resistant 
strains that makes the need for identifying new drug targets paramount in antimalarial 
research. The World Health Organization monitors the identification and spread of resistant 
strains. However, the coordination and standardization of tests and sample analysis has 
complicated the accurate identification and tracking of the latest drug resistant strains 
(Talisuna et al. 2012). The drive for new drug targets could be mitigated by the development 
of vaccines against P. falciparum, however to date there is no effective vaccine available. 
There are several candidates being developed and tested, but so far none have proven 
successful (Heppner 2013). A better understanding of Plasmodium biology is crucial for the 
development of new drug targets to counter the rapid development of resistant strains and the 
development of effective vaccines. 
 
Disease History 
The protozoan organism Plasmodium is a microscopic parasite transmitted by the bite 
of the female Anopheles mosquito. Early medical writing in the Middle East and China 
described the unique periodic fevers that are characteristic of malaria. In the fifth century BC 
Hippocrates described the different fever cycles indicative of the disease showing just how 
long mankind has been subject to this infection (Neghina et al. 2010). The word malaria 
comes from the Latin words “mal” meaning bad, and “aria” meaning air.  The fevers that 
come with the parasitic infection were first associated with dank misty swamp areas, which is 
the ideal breeding ground for mosquitoes. Attempting to combat the presumed source of the 
disease they would fill in the swamps, subsequently halting the spread of the disease by 
destroying the mosquito’s breeding ground. The actual cause of malaria, Plasmodium, was 
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discovered in 1880 with the use of microscopes. The first parasite was visualized in1880 by a 
French army doctor named Charles Louis Alphonse Laveran. He described a foreign body 
inside the red blood cells (RBCs) of a sick soldier suffering from malaria. By 1898 scientists 
had proven that the mosquito was the vector responsible for the spread of the disease (Hafalla 
et al. 2011).  
 
Life Cycle 
 Five different species of Plasmodium have been found that can infect humans: 
Plasmodium falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi. Each of the 
different species behave similarly, yet are different enough that they can be distinguished as 
separate species pathologically. When an infected female Anopheles mosquito takes a blood 
meal from a human the Plasmodium sporozoites are transmitted by the saliva. Once inside 
the human host, the sporozoites travel through the bloodstream to the liver, and enter the non-
erythrocytic life cycle. In the liver they actively invade the resident parenchymal cells and 
form parasitiphorous vacuoles inside of the parenchymal cells (Hafalla et al. 2011). Inside 
the liver each species of Plasmodium behaves differently, but with the common goal of 
proliferation. The sporozoites go through a process of binary fission to reproduce rapidly. 
Each species has a different parasite yield and time span during this process. The structures 
formed by these rapidly dividing parasites in the parenchymal cells are known as 
cryptozoites. P. vivax and P. ovale have the ability to create dormant forms known as 
hypnozoites. The cryptozoites fill the hijacked parenchymal cell with vesicles packed with 
parasites known as merosomes. The number of merosomes produced during this stage, and 
the time it takes to rupture the cell, is indicative of each Plasmodium species.  
The rupture of the infected liver cells results in the release of hundreds of merosomes from 
the cryptozoite into the bloodstream. The merosomes travel to the lungs where they rupture 
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and release the merozoites packed inside. The release of merozoites into the bloodstream 
initiates the intraerythrocytic cycle of Plasmodium spp. All symptoms and pathology are 
caused by this particular cycle of the infection (Baer et al. 2007, Prudencio et al. 2011). Once 
inside the bloodstream merozoites invade RBCs. P. falciparum has no preferred erythrocyte 
stage to invade while P. vivax prefers young RBCs known as reticulocytes (Mons, 1990). 
Once inside the RBC the parasite begins to quickly replicate utilizing hemoglobin as its food 
source. Entrance into the intraerythrocytic cycle is identified by the penetration of the RBC 
and the formation of the parasitic vacuole. After the initial invasion the parasite develops into 
a trophozoite. The early trophozoite is called the ring stage due to its morphology. As the 
parasite feeds it develops into the trophozoite stage, losing the ring morphology. Lastly the 
trophozoite commences replication and matures into a schizont. The schizont stage is 
characterized by the development of multiple merozoites and ending when the RBC ruptures. 
The newly developed merozoites enter the bloodstream to infect new RBCs and repeat the 
cycle. The parasite can also undergo a sexual proliferation cycle where the parasite replicates 
sexually. This occurs when gametes, known as microgametocytes and macrogametocytes, are 
formed instead of a schizont. When the RBC ruptures it frees these haploid gametes into the 
circulation. These gametocytes are ingested by the female Anopheles mosquito during a 
blood meal. Inside the stomach of the mosquito the microgametocytes and macrogametocytes 
merge and form a zygote. The sexual recombination of the two gametocytes in the gut of the 
mosquito leads to genetic recombination (Walliker et al. 1987). During the sexual 
reproduction stage the zygotes develop into oocysts. Theses oocysts form in the wall of the 
mosquito’s gut where they mature and produce sporozoites. These sporozoites migrate to the 
salivary glands of the mosquito where they are eventually transmitted to the human during 
the next blood meal via the salivary secretions (Fig. 1). 
5 
 
 
 
Figure 1. Life cycle of Plasmodium. Plasmodium has two different hosts and three different 
stages of development. Asexual reproduction occurs in two separate stages in the human host 
and sexual reproduction occurs in the gut of the mosquito host (Derbyshire et al. 2011). 
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Pathology 
The clinical symptoms of malaria can take more than a week to manifest after the 
initial infection. The liver stages of infection do not typically cause pathology, it is only after 
the intraerythrocytic cycle begins that the infected individual shows signs of illness. Major 
symptoms include fever, chills, arthralgia, vomiting, jaundice, and anemia. The classic 
symptoms are chills followed with fever and sweating lasting four to six hours and cycles 
every two to three days depending upon the species of Plasmodium causing the infection 
(Akinosoglou et al. 2012). This study focuses on Plasmodium falciparum, which typically 
causes a cyclic fever that recurs every 36-48 hours. The rupture of the RBC leads to the 
classic clinical signs of malaria; anemia, fever, and chills. When the infected RBC ruptures it 
releases metabolic waste products and merozoites into the bloodstream. In the 
intraerythrocytic cycle Plasmodium goes through several cycles of invading RBCs, 
replicating inside of them, consuming the hemoglobin, bursting the cell, and invading new 
RBCs (Fig. 2). Ruptured RBCs release metabolic waste products from the consumption of 
hemoglobin by P. falciparum. The metabolic wastes released overwhelm the liver and lead to 
jaundice. The ruptured RBCs inundate the bloodstream with merozoites causing a fever as 
the immune system reacts to the sudden load of non-self parasite antigens. The newly 
released parasites quickly invade RBCs, essentially removing themselves from detection by 
the immune system, and the fever subsides. Each passage through the intraerythrocytic cycle 
consumes a greater number of RBCs and leads to anemia (Gerald et al. 2011).As the RBC is 
invaded it undergoes specific physical changes induced by the parasite and general physical 
changes in response to being invaded. The membrane of the RBC is extremely strong and 
flexible compared to most animal cells because of the high pressures and physical stresses it 
endures while traversing small capillaries. The strength and flexibility of the cell is due to the 
cytoskeleton containing protein complexes largely composed of an actin and αβ spectrin 
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Figure 2. The intraerythrocytic cycle of Plasmodium falciparum. Merozoites infect a RBC 
and mature. The first stage, the ring stage, is identified by a small ring-like structure in the 
RBC. The second stage, the trophozoite, is characterized by an expanding cytoplasm and 
increased size of the parasite within the RBC. The third stage, the schizont, is characterized 
by multiple nuclei forming in the RBC as the parasite completes replication and prepares to 
rupture the RBC. 
 
 
 
 
London school of Hygiene and Tropical Medicine 
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dimer-based network connected to the cell membrane by anchor proteins (Zuccala and Baum 
2011). Parasitic invasion causes the rearrangement of the cytoskeleton during the formation 
of the parasitic vacuole and the subsequent alterations cause a loss in the flexibility of the 
RBC membrane. 
 The spleen is responsible for removing old and damaged RBCs from the bloodstream 
under normal conditions (Buffet et al. 2011). The vasculature of the spleen is split into two 
pathways; fast flow and slow flow. The fast flow region bypasses the majority of the spleen’s 
functions and returns the blood to the rest of the body. The slow flow route is specially 
designed to slow the flow of red blood cells and bring them into close contact with 
endothelial cells and macrophages. This pathway exposes the RBC to the smallest capillary 
beds in the body. These capillary beds test the flexibility and integrity of the cell membrane. 
Macrophages comprise half of the cell population in these low flow/high stringency vessels, 
allowing close contact and long exposure time between the macrophages and the RBCs. The 
lengthened time and increased proximity allows the macrophages to engulf compromised 
RBCs through ligand-receptor mediated mechanisms. The expression of phosphatidylserine 
(PS) on the surface of RBCs is the prominent ligand-receptor mediated process for 
macrophage binding and phagocytosis. Structural abnormalities that compromise the 
flexibility of the membrane cause the RBC to rupture in the high stress conditions of the slow 
flow route (Buffet et al. 2011). Infected RBCs undergo oxidative stress from the invasion of 
Plasmodium. The oxidative stress leads to the initiation of cell death and results in the 
exposure of PS on the outer membrane of the RBC in a calcium-dependent manner (Foller et 
al. 2009), (Nguyen et al. 2011). The Tim-4 receptors on the surface of the macrophage bind 
to the PS and initiate phagocytosis. This ligand-receptor pathway is responsible for clearing 
damaged RBCs from the bloodstream. The increase in the number of RBCs being cleared 
during infection puts strain on the spleen. The red pulp of the spleen becomes overwhelmed 
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with infected RBCs and the white pulp becomes disorganized as an increase in macrophages 
compromises the structure. This strain causes the spleen to enlarge and creates a condition 
known as splenomegaly (Chua et al. 2013).  
 P. falciparum has developed a method to avoid clearance by the spleen. The parasite 
attaches cysteine rich proteins onto the outer surface of the RBC membrane. Inside the 
smaller vessels of the vasculature these cysteine rich domains interact with CD-36 expressed 
on the surface of the endothelial cells lining the blood vessel. This interaction allows the 
parasitized RBC to bind to the capillary wall and avoid clearance by the spleen (Fonager et 
al. 2012). 
Cerebral malaria is defined as altered consciousness, spasms, coma, and eventually 
death as the blood flow to the brain becomes compromised. Interaction between the infected 
RBC (iRBC) and the endothelium of the brain are driven by ICAM1 and CD-36 expression 
on the surface of the endothelial cells and the P. falciparum erythrocyte membrane protein 1 
(PfEMP1) expressed on the surface of the iRBC. There are also interactions between Pfemp-
1 and complement receptor 1 (CR-1) on the surface of erythrocytes allowing the iRBC to 
bind to uninfected RBCs, forming rosettes in the bloodstream. The combination of iRBCs 
binding to uninfected RBCs, and the endothelial cells lining blood vessels, leads to 
aggregates that can block the flow of blood in the brain and cause cerebral malaria (Dondorp 
et al. 2004).  
 
Plasmodium cell cycle 
 Plasmodium falciparum is a single-celled eukaryote. The parasite undergoes the 
normal stages of the eukaryotic cell cycle; G0, G1, S, G2, and M. G0 is the nomenclature used 
for the constitutive processes that the cell undergoes to maintain its functioning state. Once 
the cell has received the appropriate signals to divide, it reaches G1. During this stage it 
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prepares to replicate its genome by synthesizing the appropriate cellular machinery required. 
Once the cell has enough of the appropriate enzymes it begins to synthesize a new genome, 
entering the S phase. When the genome has been duplicated it enters the M stage and the 
DNA is mechanically separated and the cytoplasm cleaves in two, completing the cell cycle. 
 The cell cycle is strictly controlled by a series of checkpoints that monitor each stage. 
The regulation of the cell cycle is conducted by a highly conserved family of proteins known 
as cyclin dependent kinases (Cdks). The Cdks regulate the cell cycle by phosphorylating 
specific target proteins. Targeting and activation of the Cdk is regulated by the cyclin protein 
bound to it. In this manner a single kinase can have different effects and targets at different 
stages of the cell cycle. This mechanism for regulating cell cycle progression is conserved 
across all eukaryotes. Over time there has been a divergence in the timing and targets of the 
cyclin proteins. One cyclin may be used in fungi to initiate G1 growth, while mammalian 
cells might use that same cyclin to initiate the S phase. The core functional domains have 
remained conserved, but over time variation has led to large families of Cdks and cyclins 
with targets and effects that can vary by organism. (Cross et al. 2011). 
 Coinciding with the tightly regulated progression of the cell cycle are the stage 
specific requirements of the cell cycle. The progression of each stage instigates a coordinated 
array of molecular mechanisms to conduct the mechanical processes required by that stage. 
G1 requires the production and duplication of the cellular organelles and all of the subsequent 
protein structures required to support and produce those organelles. The S phase requires the 
up-regulation of DNA synthesis and the expression of appropriate proteins for organizing and 
packaging the duplicated genome. The M phase requires another set of specific proteins and 
enzymes for mitosis and cleavage. 
There are several different factors that can be used to determine the initiation of 
mitosis. One of these factors is the organization of the mitotic spindle and the migration of 
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the centrioles to the proper positions on the nuclear membrane. The centriole is then 
responsible for physically separating the genomes. Centrioles are structures consisting of nine 
microtubule triplets. This configuration of microtubules is present in many structures within 
the cell, including centrosomes and cilia. Centrosomes are the main microtubule-organizing 
center (MTOC). The MTOC is comprised of two centrioles, which are considered to be the 
main bodies involved in the separation of DNA during mitosis (Debec et al. 2010). At the 
core of the centrosomes are the centrioles. During mitosis the centriole replicates and forms a 
daughter centriole within the centrosome. The centrosomes then migrate along the nuclear 
envelope and form the poles of the bipolar spindle assembly, which separates the 
chromosomes during mitosis. Disruptions to the centrosome duplication cycle can cause 
chromosome instability and lead to genetic instability. These consequences require the cell to 
tightly regulate the replication and division of centrosomes and their subsequent migration 
across the nuclear envelope to establish the mitotic spindles (Mardin and Schiebel 2012). 
Plasmodium species are eukaryotic apicomplexans that share many similarities with 
mammalian cells. While they have the same general cell cycle, there are several distinct 
differences that are poorly understood. The life cycle of Plasmodium includes two different 
host organisms and three distinct cycles. This study is focused on the intraerythrocytic cycle 
of P. falciparum that occurs in humans. During typical eukaryotic mitosis the DNA is 
condensed into chromosomes, centrosomes localize to the nuclear envelope, replicate, and 
then migrate to the poles. Microtubules from the MTOC connect to the chromosomes at the 
kinetochore during metaphase. Then the opposing centrioles separate the genome as the 
microtubules are shortened during anaphase. Nuclear membranes form around the now 
separated chromosomes during telophase and the daughter cell is soon cleaved from the 
mother cell. P. falciparum does not undergo chromosome condensation, but it does have 
kinetochores that attach the DNA to the MTOC. The nuclear membrane remains intact during 
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mitosis. This means that the nuclear envelope must be divided among several daughter cells 
after replication has occurred. A single merozoite produces multiple progeny during 
schizogony.  This means that several genomes are being synthesized, and then replicated, 
inside of the nuclear membrane during schizogony. The stages of S/M can be asynchronous 
between the developing progeny. One genome can be undergoing mitotic separation while 
another, within the same schizont, may be in S phase.  Cleavage of the nuclear membrane is 
indicated by furrows developing in the membrane around the separate daughter cells and 
affects all progeny simultaneously.  The simultaneous initiation of cleavage suggests that 
there is a mechanism in place that governs the end of schizogony and brings all of the 
genomic progeny to completion in a timely fashion (Gerald et al. 2011).  
The eukaryotic cell cycle is rigidly regulated by the interplay between Cdks and the 
cyclins they bind. To date there is still very little known about the regulation of the cell cycle 
in P. falciparum. There are only two proteins known to regulate nuclear division (Fu et al. 
2007, Mahajan et al. 2008). One of these proteins is a centrin. Centrins are proteins known to 
play roles in regulating nuclear division and centrosome duplication. Four centrins were 
identified in P. falciparum using comparative genetics and analyzed for their role in nuclear 
division. Centrins contain calcium-binding sites and are responsible for driving the 
contractile mechanics of the microtubules during mitosis. Four proteins in Plasmodium share 
homology with mammalian centrin proteins. Subsequent investigation found that one of the 
P. falciparum centrin (PfCEN) molecules had a role in cell cycle regulation. PfCEN3 co-
localized with the MTOC during nuclear division and the dysfunction of this protein resulted 
in the arrest of cell cycle progression (Mahajan et al. 2008). 
The only other protein known to regulate the intraerythrocytic cell cycle is an aurora 
related kinase (Fu et al. 2007). There are several different families of kinases that are crucial 
during the cell cycle. Each of these kinase families play roles in driving the mechanics 
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involved in the duplication of centrosomes, their migration to the poles of the nucleus, the 
separation of the genome, the contraction of microtubules, the formation of new nuclei, and 
membrane cleavage. Aurora kinases (ARKs) are serine/threonine-phosphorylating enzymes 
that are crucial for the appropriate segregation of chromatid during mitosis. Aurora kinases 
were first discovered in Drosophila. The name aurora comes from the mono-polar spindle 
formation, reminiscent of the aurora borealis, which results when the gene is mutated and the 
centrosome does not divide properly. Mammalian cells have 3 different ARKs; A, B, and C. 
These three ARK proteins are significantly similar, with 70% amino acid sequence 
homology. The variable portions of the three proteins are the binding domains of the ARKs. 
ARK A is primarily found in pericentriolar material during the S and G1 phase where it 
attaches to the proximal ends of the spindle microtubules. ARK A is an important component 
in spindle assembly formation and ensuring that the centrosome functions properly. ARK B 
is known to bind to three different partners, and the binding partner determines the 
localization and function of the kinase. ARK B has been shown to be crucial for proper 
kinetochore-microtubule attachment, a spindle checkpoint kinase, and a regulator of 
chromatin modification. The two ARKs, A and B, are involved in mitosis and the third ARK 
is involved in meiosis. In mammals ARK C is mainly found in the testes, where it serves a 
regulatory role in (Fu et al. 2007). Genomic analysis of the P. falciparum identified three 
homologues to aurora kinases. One ARK in particular shows conservation across the 
different Plasmodium species and a conserved orthologue in other apicomplexans. P. 
falciparum aurora kinase (PfARK-1) was shown to co-localize with the centrosome body 
during the formation of bipolar mitotic spindle bodies. This makes it more similar to ARK A 
in mammals with its localization to the centrosome. The genetic disruption of this protein 
resulted in an inability of the parasite to grow in culture, identifying it as a crucial gene for 
the intraerythrocytic cycle (Reininger et al. 2011). 
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Plasmodium genomics 
The rise of drug resistant strains coupled with little progress in managing malaria 
over the last century led to a joint project to sequence the genome of P. falciparum in hopes 
of revealing a better understanding of the parasite (Gardner et al. 2002). The collaboration of 
several labs over several years completed the genome sequence for the P. falciparum strain 
3D7 in 2002. After sequencing and homology analysis the collaborators determined that 60% 
of the genome was made of genes of unknown function. The majority of the genome was 
composed of genes with no significantly homologous genes in other known genomes 
(Elyazar et al. 2011). Modern genetic techniques have been adapted to investigate the 
function of these unknown genes. There are now several databases and genomic tools that 
can be used by investigators. Scientists use these techniques and databases to determine 
similarities with other genes and make predictions about the structure or function of their 
gene of interest. This information is used to infer protein function and aid them in their 
investigations (Di Girolamo et al. 2005).  
The new databases and online software platforms have been extremely useful in 
predicting the roles of unknown genes in Plasmodium. Another approach for understanding 
the function of P. falciparum genes is through genetic manipulation. Genetic experimentation 
to determine the role of a gene en vivo can be done by two different methods; forward 
genetics and reverse genetics.  
The classic approach to determine the function of a gene of interest is reverse 
genetics. The technique compares the sequence of a gene of interest against other sequences 
in a comprehensive database. The resulting list of homologous genes allows the investigator 
to determine the most likely function of their gene of interest. The gene is then disabled to 
verify that the gene of interest does in fact perform a function similar to the known 
homologous genes.  Homologous recombination is used to disable the gene of interest. The 
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insertion of a strand of foreign DNA into the sequence of interest functionally disables the 
gene. The function of the gene of interest can be characterized by the effects of its absence. 
The quantity of unknown genes in the Plasmodium genome makes reverse genetics an 
ineffective approach for understanding this complex and deadly parasite.   
Forward genetics is a process where a collection of mutants is created by randomly 
disabling a single gene in multiple individuals. The mutants are then subjected to a 
phenotypic screen. Analysis of the screen identifies mutants with a phenotype of interest. 
Once a mutant with a significant phenotype is identified the genome is sequenced to 
determine which gene was disrupted.  
The use of forward genetic tools to analyze the proteome of P. falciparum is a 
difficult process largely because of low transfection efficiency. Transfection efficiency is a 
measure of what number of the intended target organisms are actually being transfected. 
Standard transfection techniques used on Plasmodium spp. yields an efficiency of  1x10 -6. 
When attempting to insert genome-altering foreign DNA constructs into malaria, the material 
has to cross the membrane of the RBC, the membrane of the parasitic vacuole, the membrane 
of the parasite, and then enter the nucleus of the parasite (Balu and Adams 2007). The 
development of transposon based mutagenic techniques has allowed the field to overcome the 
difficulties of forward genetic transfection because of the increased number of locations 
where homologous recombination can occur. Transposable elements (TE), or ‘jumping 
genes’, are highly conserved elements found in a wide variety of genomes. The TEs have 
binding sequences of low complexity making integration by the transposase enzyme more 
likely because of an increase in the number of locations for insertion and a decrease in the 
length of homologous sequences. This low complexity strategy supplies the TE with a 
plethora of viable insertion sights in any genome (Balu et al. 2005, Fonager et al. 2011). The 
piggyBac transposable element has an insertion sequence of TTAA, and there are 
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approximately 300,000 possible sites for insertion into the genome of P. falciparum. The 
insertion of the piggyBac element has been found to be completely random, showing no 
preferences between genes or chromosomes in P. falciparum (Balu 2012). This modification 
increased the transfection efficiency of experiments from as little as 10−6 in typical reverse 
genetic transfection experiments to as high as 1-10 insertions per transfection with the 
piggyBac method, making the forward genetics screening process both viable and efficient. 
The increased transfection efficiency of using the piggyBac transposable element to mutate 
the genome of P. falciparum has allowed scientists to overcome the difficulty of 
manipulating its genome (Balu et al. 2009).  
 
Mutant Identification 
Utilizing the piggyBac method a forward genetic screen for attenuated growth 
identified several P. falciparum NF54 insertional mutants, one in particular was a mutation of 
the gene PF3D7_1143500 (Balu et al. 2010). PF3D7_1143500 is a gene of unknown function 
from the cloned strain of P. falciparum identified as 3D7 and it is located on chromosome 11. 
The gene itself is constitutively conserved across all Plasmodium spp, consisting of 2774 
base pairs (bp), with a coding sequence of 2674 bp, and the gene has a 20% GC content in P. 
falciparum. Not only is the sequence highly conserved, but so is its location (Fig. 3). This 
gene has a partial sequence homology to the Regulator of Chromatin Condensation 1 (RCC1) 
domain from human cells. 
RCC1 proteins are widely varied and highly conserved proteins organized into 
superfamilies. The superfamilies are organized by structural similarity and function. Each 
member of the RCC1 family contains homologous repeats of a 51-68 amino acid residue 
motif that adopts a seven-bladed -propeller fold, which has been shown to have a wide 
range of functions. Members of the RCC1 superfamily perform a myriad of cellular  
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Figure 3. Cross species chromosomal alignment. Diagram of the location of 
PF3D7_1143500 on chromosome 11 with homologue alignment from other Plasmodium spp. 
Genome browser view from plasmodb.org of PF3D7_1143500 and the homologues across 
multiple species of Plasmodium, including members that do not infect humans. The 
highlighted box shows the synteny of the gene across multiple species. 
(http://plasmodb.org/plasmo/showRecord.do?name=GeneRecordClasses.GeneRecordClass&
source_id=PF3D7_1143500&project_id=PlasmoDB)  
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functions: guanidine exchange, enzyme inhibition, DNA binding, interactions with proteins 
or lipids. Members of the superfamily have a variable number of repeats of the homologous 
sequence and have been further categorized into five groups (Hadjebi et al. 2008). This novel 
protein, PF3D7_1143500, which will be referred to as the P. falciparum RCC1-Like Protein 
1 (PFRLP1), contains three repeats of the RCC1 domain. While the specific function of 
PFRLP1 is unknown the phenotypic screen suggests that it plays a role in proper mitosis and 
intraerythrocytic schizogony. 
In humans, RCC1 is a critical protein in the regulation of transporting proteins across 
the nuclear membrane. This process is strictly regulated by a large variety of protein 
interactions in the eukaryotic Ran-RCC1 pathway. This pathway utilizes a GDP gradient to 
drive the transfer of proteins across the nuclear membrane. To regulate and facilitate protein 
import into the nucleus proteins targeted for the nucleus bind to importin proteins. The bound 
importin then interacts with Ran-RCC1 proteins and are then shuttled across the nuclear 
membrane.  Several members of the importin family of proteins are known to bind to target 
ligands and the RanGDP protein, then via the Ran-RCC1 pathway, transport these proteins 
into the nucleus. Once inside the nucleus RCC1 acts on the RanGDP-importin complex. 
RCC1 phosphorylates Ran GDP to Ran GTP which causes the release of the imported protein 
from importin. The process of exporting is regulated in a similar manner. There are families 
of exportin proteins that bind to specific ligands inside the nucleus. Then the exportin 
complex interacts with Ran GTP to be exported from the nucleus. Along with the families of 
proteins that bind the targets for import and export there are a few crucial proteins that work 
within the Ran-RCC1 pathway to facilitate the cycle in eukaryotic cells. All known 
eukaryotes have homologues to these proteins, which infers the importance of this pathway to 
mediate the import and export of proteins to and from the nucleus. Plasmodium does not yet 
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have any known homologues to these proteins (Frankel and Knoll 2009), (Hadjebi et al. 
2008).  
There are several RCC1 like proteins that have homology with the different motifs of 
RCC1. There are proteins that utilize the guanidine nucleotide exchange factor motif of 
RCC1 but have no role in nuclear membrane transport. There are several ways in which cells 
can use a GTP gradient to perform a variety of functions. This motif is known to regulate the 
proper functioning of motor neurons by stimulating the enlargement of endosomes and 
regulating endosomal dynamics in cortical neurons (Otomo et al. 2003). Other RCC1 like 
proteins have been found to play roles in regulating the progression of mitosis. The NIMA-
like kinase Nercc1 shares homology with RCC1s binding sight for Ran-GTPase. Nercc1 has 
been shown to be capable of arresting the progression of mitosis under experimental 
conditions (Roig et al. 2002). Another RCC1 like protein, DelGEF, has been characterized 
and identified as an important gene in hearing. The expression of splice variants and over 
expression of DelGEF have been shown to cause deafness in humans (Uhlmann et al. 1999). 
RCC1 has a guanidine nucleotide exchange motif that is shared among many proteins and 
this well-conserved functional motif is utilized by a variety of different organisms to conduct 
a wide diversity of cellular functions. 
 
Project Goals 
  The rise, and spread, of drug resistant strains has created a need for a better 
understanding of P. falciparum. The cryptic Plasmodium genome has made progress elusive, 
however the development of modern genetic tools has greatly aided this endeavor. The 
piggyBac transposable element was used to create a library of mutants and a phenotypic 
screen revealed a mutation with a significant impact on parasite proliferation in vitro. This 
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study proposes to identify the role that this crucial gene, PF3D7_1143500, plays in the 
intraerythrocytic proliferation of P. falciparum. 
 
The specific aims of this project are as follows: 
Aim1- Characterize the protein product for PF3D7_1143500. Perform comparative 
bioinformatic analysis to determine the presence of any domains of interest and develop 
methods for visualizing the protein product. The bioinformatic analysis was performed 
using online software and databases to identify sequence homologies with known domains or 
protein motifs. Partial homologies were identified and used to gain insight into the possible 
functional pathway in which the protein interacts. Analysis of the predicted amino acid 
sequence was done to determine a sequence of optimal antigenicity for the development of 
antibodies against PFRLP1. The antiserum developed from the identified sequence was used 
to characterize the expression timing and sub-cellular localization of the protein. 
 Aim2- Perform a comparative analysis of the intraerythrocytic cycle to 
characterize the phenotype of the mutant strain for insight into the function of 
PF3D7_1143500. Assays were conducted to identify the role that the PF3D7_1143500 gene 
product has in the regulation of intraerythrocytic proliferation. The differences in the 
intraerythrocytic cycle between mutant and wild type parasites were determined using 
microscopic visualization, flow cytometry, immunohistochemistry, and in vitro assays. 
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Materials and Methods: 
Cell culture conditions 
 
P. falciparum clones were maintained in human RBC culture as previously described 
(Trager and Jensen 2005). Cultures were incubated at 37°C in an environment of 5% O2, 5% 
CO2, and 90% N2. Culture media was RPMI 1640 (Invitrogen) with a 5% hematocrit of 
human blood supplemented with 0.5% Albumax I (Invitrogen) or 10% human AB sera 
(VWR scientific), 0.25% sodium bicarbonate and 0.01 mg/mL gentamicin. Human blood was 
acquired from Virginia blood services and washed 3 times in RPMI 1640. A week’s supply 
of fresh blood was washed three times in RPMI 1640 and resuspended to a 50% hematocrit 
and stored at 4C.  
 
Ring stage culture synchronization 
 To synchronize parasites in the early trophozoite ring stage, P. falciparum infected 
RBC (iRBC) cultures were centrifuged at 1200 x g for 5 minutes at room temperature (RT). 
The supernatant was decanted and the pellet containing iRBCs was resuspended in an equal 
volume of 5% sorbitol (Sigma) in RPMI 1640. The mixture was incubated at RT for 10 
minutes with intermittent mixing, then centrifuged at 2000 x g for 5 minutes at RT. The 
supernatant was removed and the pellet containing iRBCs was resuspended in normal 
complete culture media to the initial volume and returned to the incubator at the previously 
mentioned conditions. The procedure was repeated 8 hours later to yield cultures of highly 
synchronized ring stage parasites and was confirmed by microscopy. 
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 Late stage parasite purification 
 The purification of parasites in the late stage of the intraerythrocytic cycle were 
purified for in vitro assays. High parasitemia cultures (approximately 5-10% parasitemia) 
were passed through a MACS magnetic column (Miltenyi Biotech) attached to a high power 
magnet. The iron built up in the parasite from the metabolism of hemoglobin anchored late 
stage iRBCs to the magnetized column while RBCs infected with early stage parasites passed 
through the column. The column was washed with 30 mL of incomplete RPMI 1640 to wash 
out early stage iRBCs and uninfected RBCs. The column was removed from the magnet and 
the late stage parasites bound to the previously magnetized column were eluted in 20 mL of 
incomplete RPMI 1640 and centrifuged at 1200 x g for 5 minutes. The pellet containing 
purified iRBCs was washed in complete media and then resuspended in 5 mL of complete 
media at 5% hematocrit. 
  
Genomic DNA extraction 
Frozen parasite pellets were re-suspended in tris sodium EDTA (TSE) buffer (50mM 
Tris pH. 7.5, 0.1M NaCl, 0.1MM EDTA), washed three times in TSE buffer, and then lysed 
in 300 L of 2% sodium dodecyl sulphate (SDS) in TSE. Following the addition of 200 L 
of 7.5% ammonium acetate, DNA was precipitated using an equal volume of isopropanol and 
centrifuged at 12,000 x g and washed with 70% EtOH.  The DNA pellet was air dried and 
dissolved in 20 L of tris EDTA (TE) buffer.  
 
RNA extraction  
Parasites extracted from 5ml cultures were re-suspended in 0.5ml of Trizol followed 
by the addition of 100 L of chloroform and then centrifuged at 12000 x g for 5 minutes. The 
upper phase was mixed with 300 L of isopropanol and centrifuged at 16000 x g for 45 
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minutes. The RNA pellet was then washed three times in 70% EtOH, air dried, and dissolved 
in H2O.  
 
RT-PCR 
RT-PCR was performed to check for the presence of PFRLP1 gene expression. The 
RNA isolated from parasite cultures was first treated with TURBO DNA-free™ (am1907) 
kit. SuperScript® III One-Step RT-PCR System with Platinum® Taq High Fidelity 
(Invitrogen, 12574-030) was used for the reverse transcription reaction and PCR with 
specific primers for the PFRLP1 transcript. Actin was used as a reference gene for a positive 
control. DNase treated RNA was used as template for a negative control with Platinum Taq 
DNA Polymerase High Fidelity (Invitrogen, 11304-011) and actin primers.  The size of the 
PFRLP1 transcript PCR product was confirmed by gel electrophoresis.  
 
Proliferation assay 
iRBC cultures were purified using the late stage purification to isolate late 
trophozoites and schizonts. The purified iRBCs were then introduced into fresh un-
parasitized RBC culture. The culture was seeded with the purified iRBCs to an initial 1% 
parasitemia and cultured for eight days. Cultures were diluted as needed to maintain a healthy 
level of parasitemia (0.5% - 2%). Smears of the iRBC cultures were made daily to monitor 
the parasitemia level. The smears were air dried, stained with Geimsa for ten minutes, rinsed 
in H2O, and then air dried. Slides were visualized using a microscope and 1000 cells were 
counted to determine the percentage of iRBCs. 
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Flow cytometry 
 Culture samples were taken every 4 hours over an 80 hour time span and processed 
for flow cytometry to determine the intraeyrthrocytic cycle time. For each sample 200 L of 
iRBC cultures were centrifuged at 450 x g for 3 minutes then the media was removed from 
the pellets. The pellets were then resuspended in 200 μL of 0.05% glutaraldehyde in PBS and 
mixed by pipetting up and down 4 times. The cells were incubated for 10 minutes at RT and 
then centrifuged at 450 x g for 3 minutes. The supernatant was removed and pellets were 
resuspended in 200 μL of permeabilization buffer (0.3% TritonX-100 (Sigma)) in PBS. The 
iRBCs were incubated for 10 minutes at RT and centrifuged at 450 x g for 3 minutes. The 
supernatant was removed and then 200 μL of PBS was added to wash the cells. The iRBCs 
were centrifuged at 450 x g for 3 minutes, after which 200 μL of supernatant was removed 
and then 200 μL of 0.5mg/mL pancreatic RNase in PBS was added and mixed by pipetting. 
After incubating at 37°C for 1 hour the cells were centrifuged at 450 x g for 3 minutes. The 
supernatant was removed and 200 μL of 0.1 mg/mL ethidium bromide in PBS was added and 
mixed by pipetting. The cells were incubated at 37°C for 1 hour in dark, then centrifuged at 
450 x g for 3 minutes. The supernatant was then removed and 200 μL of PBS was used to 
resuspend the cells and used for flow cytometry. The fluorescence of processed samples was 
quantitated on an Accuri flow cytometer. The fluorescent intensity of ethidium bromide was 
used to distinguish single nuclei early stage parasites from multi-nucleated schizonts.   
 
Recombinant protein expression 
 EpiC online software (Bioware) was used to identify portions of the 878 amino acid 
sequence of PFRLP1 with high isoelectric points and high antigenic properties ideal for 
eliciting an immune response from a host animal. A trio of 177 amino acid sequences with 
high antigenic properties and high likelihoods of inducing the generation of antibodies were 
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identified. In order to increase the specificity of any antibodies developed the amino acid 
sequences were compared to the proteome of P. falciparum. Candidate sequences with 
multiple amino acid sequences prevalent in the proteome of the organism were excluded. The 
results were used to identify an optimal sequence with low homology to other P. falciparum 
genes and a high antigenicity score. A codon optimized plasmid from DNA2.0. was 
procured. The construct contained an Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
induction vector, the optimal sequence previously mentioned, a hemagglutinin (HA) tag, and 
a 6 x histidine tag was purchased from DNA2.0 for expression in E.coli.  
 E. coli was transformed with the plasmid. Cultures were grown in Luria broth (LB) in 
a shaking incubator at 37 C until optical density at 600 nm (OD600) of 0.6 was reached. Then 
plasmid expression was induced with 0.5M IPTG and incubating at 30 C for 8 hours. 
Cultures were then centrifuged at 6,000 x g for 10 minutes. The supernatant was decanted, 
and the bacterial pellet was flash frozen in liquid nitrogen.  
 The pellet of 1-liter of cultured bacteria was resuspended in 10 mL of lysis buffer (B-
per Pierce 78266) with 1:100 dilution of protease inhibitor (Sigma p8340). The suspension 
was then shaken for 15 minutes at RT. The suspension was put on ice and pulse sonicated at 
55% power 5 times for 10 seconds with one minute intervals between each burst. The lysed 
suspension was centrifuged for 20 minutes at 25,000 x g and the supernatant was collected. 
Nickel cartridges from Pierce scientific (Thermo Scientific 90098) were used to affinity 
purify the protein of interest. The interaction of the 6 x His tag on the C-terminus of the 
protein and the charge of the nickel column were used to isolate the protein. Samples were 
processed as per the manufacturer’s protocol. The collected elute was then concentrated 
using 50 kDa spin columns (Vivaspin).  The concentrated recombinant protein was collected 
for polyclonal anti-serum. Finally 300 g of the concentrated recombinant protein was used 
by Harlan laboratory for polyclonal anti-serum development in a rat. 
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Western Blot 
To determine the timing and level of expression of PFRLP1 parasite lysate samples 
of synchronized culture of the three blood stages were analyzed by western. Samples were 
heated to 95 C for 5 minutes in laemmli sample buffer (BioRad) and resolved on a 10% SDS 
stacking gel, then transferred to a nitrocellulose membrane at 300 mA. The membrane was 
immersed in blocking buffer (0.05% tween, 5% nonfat milk in PBS) for 1 hour at RT. Rat 
polyclonal -PFRLP1or anti -tubulin (Pierce 32230) was diluted 1:250 in blocking and then  
incubated over night at 4°C. The membrane was then washed 3 x with 0.05% tween in PBS 
(PBST) for 5 minutes at RT. The horseradish peroxidase (HRP) conjugated IgG secondary 
(Pierce Scientific), diluted1:2000 in PBST, was added and incubated at RT for 1 hour.  The 
membrane was then washed 3x in PBST for 10 minutes, developed with chemiluminescence 
(ECL plus, Pierce Scientific), and imaged with a Bio Rad gel doc system. 
 
Immunohistochemistry 
 An immunofluorescence assay (IFA) was conducted to visualize the formation of 
microtubule organizing centers (MTOCs). Cultures of purified late stage iRBC were 
transferred to fresh culture media to invade fresh RBCs. Smears of iRBC cultures were 
acquired every 2 hours from 20 hours post invasion to 38 hours post invasion for -tubulin 
staining for the first experiment. The smears were air dried, and processed as previously 
described (Mahajan et al. 2008). Slides were incubated overnight at 4°C in the primary 
antibody (α-tubulin (Sigma) and/or rat antiserum) diluted 1:100 in blocking buffer. The 
secondary, Dylight 488 anti-mouse (KPL) diluted 1:100 in PBS and Hoechst 10 g/mL, was 
added to the slide and incubated in the dark at room temperature for 1 hour then rinsed. After 
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rinsing off the secondary the slide was mounted and analyzed as below. The co-localization 
experiment required another stain after the -tubulin staining. Smears were made from 
samples taken from a non-synchronized culture, then stained with -tubulin as previously 
described. After the -tubulin secondary was rinsed off of the slide the smears were labeled 
with rat polyclonal -PFRLP1 primary diluted 1:100 in blocking buffer. The secondary, goat 
anti-rat PE was diluted 1:100 in PBS with Hoechst 10 g/mL, added to the slide and 
incubated for 1 hour at RT in the dark. . The slides were then washed 3 x in PBS at RT for 5 
minutes, mounted and cover-slipped, then stored in the dark until visualized a Nikon TE 
2000-E microscope using fluorescence at 600X magnification 
 
Transfection of Degradation Domain and Selection:  
A conditional knockout study was conducted in order to confirm that the phenotype 
of the mutant was solely caused by the dysfunction of PFRLP1. PFRLP1 null parasites were 
ring stage purified as described above (Lambros and Vanderberg 1979). The synchronized 
culture was grown in culture through two intraerythrocytic cycles, and the schizonts from the 
second cycle were isolated via magnetic column (Miltenyi Biotec) as previously described 
(Balu et al. 2005). The schizonts were used to invade RBCs containing the degradation 
domain plasmid. The plasmid contains the functional PFRLP1 gene, degradation domain, and 
a human dihydrofolate reductase (DHFR) selection sequence. Erythrocytes were loaded with 
150 g of plasmids containing the degradation domain construct, and electroporated as 
previously described (Balu et al. 2005, Deitsch et al. 2001). Four million schizonts were 
added to the culture of transfected RBCs. After four days of growth the cultures were treated 
with the antimalarial drug WR99210 (sigma W1770) which selectively inhibits parasite 
DHFR, not human DHFR, and halts nucleotide synthesis. The selection cassette allows 
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parasites that have been successfully transfected to proliferate in the presence of WR99210. 
However, P. falciparum can retain the plasmid without genomic integration. To select for the 
parasites with genomic integration the cultures were treated with and without WR99210, at 
two-week intervals, over several months to enrich the culture with successfully transfected 
parasites.  
 
Southern blot: 
 The correct location of the insertion of the degradation domain in the genome was 
verified for the conditional knockout study. Genomic DNA was isolated as described above. 
Briefly, 5 g of genomic DNA was digested overnight at 37°C with either EcoRV or Bgl II 
(New England Bio). The digested DNA was separated via electrophoresis on a 0.8 % 
Agarose gel at a constant 100V for 2 hours. Digestion of the DNA was confirmed by 
ethidium bromide staining. The gel was depurinated for 5 min in a solution of 0.25 M HCl at 
RT, then transferred to a solution of 1.5M NaCl and 0.2N NaOH for 20 minutes at RT. The 
gel was equilibrated in transfer solution (1M Ammonium Acetate, 0.02N NaOH) for 30 
minutes at RT and then blotted as previously described (Adams et al. 1990). The blot was 
processed using a southern hybridization kit (Thermo scientific 17097) and biotinylated 
primers (Integrated DNA technologies).  Primer sequences specific for human DHFR present 
in the selection cassette of the degradation domain construct, forward sequence 5’ –
ATGGTTGGTTCGCTAAACTG-3’ and reverse sequence                                                   5’-
TTAATCATTCTTCTCATATACTTCAAA-3’, were hybridized with the blot overnight at 
60°C and processed per kit protocol. The blot was visualized with Bio Rad gel doc system 
and Image Lab software (Bio Rad). 
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Results: 
PF3D7_1143500 (PFRLP1) displays partial homology to human RCC1 
 The majority of the genome of P. falciparum, including PF3D7_1143500, does not 
have any homologous genes in the genomic databases. In order to gain insight into the 
possible function of PF3D7_1143500 (PFRLP1) a bioinformatics analysis was performed to 
identify partial homologies to known sequences, domains, or motifs. Protein sequence 
analysis of PFRLP1 using NCBI conserved domain search database revealed a partial 
sequence homology to the protein RCC1 (Fig. 4). The predicted amino acid sequence of 
PFRLP1 contains a nuclear localization signal and two identical sequences that are partially 
homologous to the DNA binding domain of the human RCC1 protein. RCC1 is a highly 
conserved protein with two well-defined motifs. It is known to regulate protein transfer 
across the nuclear membrane. The presence of only one motif in PFRLP1 implies that it is 
unlikely to be the as yet un-identified RCC1 homologue in P. falciparum.  A comparative 
sequence analysis of the human RCC1 sequence and the entire proteome of P. falciparum 
identified PFRLP1 to be one of ten proteins with significant partial sequence homology to 
RCC1 (Table 1). The original RCC1 protein is vital in regulating protein transport into and 
out of the nucleus. RCC1 contains two dynamic motifs, the first is a guanidine transfer motif, 
and the second is a DNA binding motif. These motifs are utilized by hundreds of proteins to 
perform a variety of functions. The gene PF3D7_1143500 is one of ten genes to share 
homology with human RCC1, it is also one of the least homologous. The nuclear localization 
signal and the DNA binding motif of RCC1 infers a role in the nucleus, but the lack of the 
second RCC1 domain make it an unlikely homologue for RCC1.  
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Figure 4. PFRLP1 protein sequence motifs. The representation of the predicted 878 amino 
acid sequence for PF3D7_1143500 reveals a partial sequence homology to the RCC1 domain 
and two nuclear localization signals (NLS) near the N-terminus. 
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Table 1. Comparative protein sequence analysis. Protein sequence analysis identified 
PF3D7_1143500 as one of ten RCC1-like proteins in P. falciparum. The list of P. falciparum 
proteins with partial sequence homology to human RCC1 protein identified ten proteins, 
seven of these proteins had a greater sequence alignment similarity to human RCC1 than 
PFRLP1.  
 
 
 
 
 
 
 
 
 
 
 
 
   Smallest Sum High Probablity 
 Gene  Score P(N) N 
1 PF3D7_1137400  Plasmodium_falciparum_3D7 264 1.50E-22 1 
2 PF3D7_0711500  Plasmodium_falciparum_3D7 203 2.20E-20 2 
3 PF3D7_0508500  Plasmodium_falciparum_3D7 154 2.20E-15 2 
4 PF3D7_1356600  Plasmodium_falciparum_3D7 180 1.20E-12 1 
5 PF3D7_0403100  Plasmodium_falciparum_3D7 86 2.30E-06 2 
6 PF3D7_0919900  Plasmodium_falciparum_3D7 130 4.40E-06 1 
7 PF3D7_0418600  Plasmodium_falciparum_3D7 85 0.01 4 
8 PF3D7_1143500  Plasmodium_falciparum_3D7 78 3.50E-01 1 
9 PF3D7_0930800  Plasmodium_falciparum_3D7 85 7.50E-01 2 
10 PF3D7_1451100  Plasmodium_falciparum_3D7 65 9.80E-01 2 
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 PFRLP1 is expressed throughout intraerythrocytic development and localizes to the 
parasite nuclear periphery. 
To obtain insights into the function of PFRLP1 in the wild type parasite the 
expression level of PFRLP1 was determined during the three stages of the intraerythrocytic 
cycle by western blot. The sub-cellular location of the protein was also visualized during the 
different stages of the intraerythrocytic cycle using immunofluorescent microscopy. In order 
to quantify and visualize the PFRLP1 protein polyclonal antiserum against PFRLP1 was 
created using recombinant protein techniques. A 177 amino acid sequence was expressed in 
E. coli and column purified to generate antiserum in a rat host (Fig. 5, panel A). The 
specificity of the rat anti-serum generated against PFRLP1 was confirmed by western blot 
after production (Harlan Laboratories). The blot showed binding of the serum antibodies to 
the original bacterial lysates, the purified recombinant protein product, and a high specificity 
in whole parasite lysate (Fig. 5, panel B). This confirmed the production of antibodies 
specific for our polypeptide sequence from PFRLP1.   
In order to determine the expression level of PFRLP1 during the intraerythrocytic 
cycle synchronized parasite cultures were used to produce whole parasite lysates of the three 
different developmental stages in the intraerythrocytic cycle; ring stage (Pre-S phase of cell 
cycle), trophozoite stage (S-Phase of cell cycle), and schizont stage (S and M phases of cell 
cycle). Subsequent analysis via western blotting revealed PFRLP1expression to be at 
comparable levels throughout the three stages of the intraerythrocytic cycle (Fig. 6, panel A). 
Immunofluorescent microscopy showed the localization of PFRLP1 to the periphery of the 
nucleus during the three stages of the intraerythrocytic cycle (Fig. 6, panel B).  
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Figure 5. Recombinant protein purification and antiserum specificity A.) The SDS PAGE 
protein blot shows the isolation of the recombinant protein from the Nickel column. The 
lanes show protein content from recombinant transformed bacterial culture whole lysate, the 
unbound lysate proteins, and the protein washed out after loading respectively. The last lane 
shows the protein eluted from the column at approximately 28 kDa (arrow), which is the 
predicted size of the 177 amino acid recombinant polypeptide. B) A western blot using the rat 
sera. The lanes show the bacterial lysate flowed through the column, eluted protein extracted 
from the recombinant bacterial culture, and the final lane is whole cell lysate from the wild 
type P. falciparum parasite. 
 
 
 
 
 
 
 
A. B. 
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Figure 6. PFRLP1 expression and localization. A) Western blot of the three stages of the 
intraerythrocytic cycle with the rat antiserum (α-PFRLP1) and anti-histone as a loading 
control. B) Immunofluorescence assay illustrates localization of PFRLP1 to the nuclear 
periphery of the three stages of the intraerythrocytic cycle (PFRLP1 in green and nuclei in 
blue). 
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Attenuation of the PFRLP1 mutant intraerythrocytic growth rate is due to a reduction 
in merozoite formation in mature schizonts. 
 The diminished growth rate observed previously in a forward genetic screen done 
previously indicated a vital function for PFRLP1 in the intraerythrocytic cycle (Balu et al. 
2010). In order to determine the role of PFRLP1 in the intraerythrocytic cycle several 
important components of the cycle were examined; intraerythrocytic cycle time, parasite 
proliferation, merozoite formation, RBC invasion, and parasite egress from the RBC.  
Intraerythrocytic cycle time is defined as the period of time that lapses from one schizont 
stage to the next. This was determined with flow cytometry analysis and confirmed by 
microscopy. A time course study was performed over 196 hours with samples taken every 
four hours. Flow cytometry was used to measure the DNA content of the iRBCs and 
determine the intraerythrocytic cycle time. The peak schizont time was determined by 
measuring the DNA content of each iRBC and the cycle time was the time between two peak 
schizont measurements. The flow cytometry data was confirmed by microscopy, samples 
from each time point were smeared, stained, and analyzed for schizont content. The 
microscopy findings confirmed the flow cytometry results. There was no observed difference 
of the intraerythrocytic cycle time between the wild type and the PFRLP1 mutant, both 
having a 48 hour intraerythrocytic cycle (Fig. 7).   
 The proliferation rate in blood culture was examined next. The determination of the 
proliferation rate was performed by determining the fold increase in parasitemia over eight 
days in blood culture. The results from analysis of the samples taken was a decrease in 
percent parasitemia in the PFRLP1 mutant, supporting the previous findings (Balu et al. 
2010) (Fig. 8).  
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Figure 7. Intraerythrocytic cycle time analysis.  Time course samples from triplicate cultures 
of mutant and wildtype parasites were taken over 96 hours at 4 hour intervals. They were 
analyzed for the percentage of schizonts by flow cytometry and confirmed by microscopy.  
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Figure 8. Intraerythrocytic proliferation assay. Fresh blood cultures inoculated with 106 late 
stage iRBCs were sampled every 24 hours over an eight day period. The samples were 
analyzed via microscopy to calculate the percent parasitemia. The data is represented as fold 
increase in parasitemia and shows significant difference in proliferation between the WT 
strain and the two mutants after 96 hours (Means ± SD are indicated and a two-tailed 
unpaired t-test was used to determine significance, * = p  0.05).   
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The next aspect of the intraerythrocytic cycle that was examined to determine the 
difference in proliferation was merozoite production. Late stage parasites were examined via 
microscopy and the number of merozoites being formed in mature schizonts was counted 
(Fig. 9, panel A). The numbers of merozoites formed within 100 schizonts were examined 
over triplicate cultures. Analysis shows a significant 40% reduction in merozoite formation 
for the PFRLP1 mutant. (Fig. 9, panel B).  
 The last facet of intraerythrocytic cycle that was examined was the ability of the 
parasite to exit the RBC and infiltrate new ones, known as egress and invasion respectively. 
This was previously examined and there was no difference found between the WT and the 
PFRLP1 mutant (data not shown)(Balu et al. 2010). 
 
Conditional mutagenesis of PFRLP1 validates its role in merozoite production. 
 A conditional knockout mutant was created using a degradation domain (DD) 
construct to verify that the observed reduction in merozoite formation was caused by the 
mutation of PFRLP1. This construct targeted the PFRLP1 protein for proteolysis directly 
after synthesis, effectively creating a dysfunctional gene (Fig. 10, panel A) The DD is 
specially designed to work with a specific inhibitor of its degradation, the shield1 compound. 
Under normal conditions the newly synthesized protein is immediately targeted for 
degradation, however, when the culture is treated with the shield1 compound, the degradation 
domain is masked and the protein functions normally. To confirm that the DD construct was 
incorporated into the genome of P. falciparum a southern blot was performed using 
biotinylated primers designed to span the human dihydrofolate reductase (hDHFR) selection 
marker and the insertion site. Two different digestion enzymes were used for verification. 
The bands appeared at the predicted sizes for positive insertion of the DD construct in the  
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Figure 9. Microscopic analysis of merozoite formation A) Giemsa-stained blood smears of 
wild-type and mutant parasites. B) The number of merozoites formed in schizonts during the 
intraerythrocytic cycle was significantly higher in the WT strain (Means ± SD are indicated 
and a two-tailed unpaired t-test was used to determine significance, * = p  0.005).   
 
A 
B 
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genome, approximately 8 kbp after EcoRV digestion and 12 kbp after BglII digestion (Fig 10, 
panel B). Triplicate cultures of shield1 treated and untreated cultures were purified for late 
stage schizonts and Geimsa stained. Merozoites were counted for 50 schizonts for each slide.  
The shield1 treated cultures produced approximately the same number of merozoites as the 
WT parasites (Fig. 10 panel C). DD cultures without shield1 treatment had a 20% decrease in 
the number of merozoites formed per schizont when compared to the WT strain. The 
insertion of the DD construct into the PFRLP1 gene, and the conditional restoration of its 
function under treatment with shield1, confirmed the effect of PFRLP1 on merozoite 
formation in the schizont stage of the intraerythrocytic cycle.  
 
Determining the initiation of mitosis for insight into the cause of the reduced number of 
merozoites. 
The cell cycle was examined after the identification, and confirmation of, reduced 
merozoite formation as the defect in the intraerythrocytic cycle of the PFRLP1 mutant. We 
specifically examined nuclear division. The beginning of nuclear division is indicated by the 
formation and duplication of MTOCs and their migration to the opposite poles of the nucleus. 
The presence, division, and migration of these complexes begin the separation of nuclear 
material and the formation of the separate merozoites (Arnot et al. 2011). A time course 
experiment was conducted to determine if the reduction in the number of merozoites being 
formed was due to a delay in the initiation of nuclear division. WT and PFRLP1 mutant 
cultures were synchronized and then sampled every two hours over a period of 16 to 36 hours 
post synchronization. The time course samples were stained with anti- tubulin for the 
detection of the MTOCs (Fig. 11). The appearance of divided MTOCs was used as the 
characteristic to determine the initiation of nuclear division via microscopy. Subsequent 
analysis of the mutant showed a significant delay of 6-8 hours in the appearance 
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Figure 10. Degradation domain merozoite formation analysis A) Schematic of the 
degradation domain construct integrated into the WT parasite genome. B) Southern blot of 
DD clones with two restriction digests. Genomic integration of the construct verified by band 
size and the presence of the hDHFR selection cassette by PCR primers. C) Graph of the 
number of merozoites formed per schizont for the degradation domain mutants cultured with 
and without the inhibitory compound shield1. 
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Figure 11. Nuclear division time Course. Indirect immunofluorescence assay on 
synchronized parasite intraerythrocytic stages over a time course (starting 16 hours post-
invasion). Samples were used to determine the appearance and separation of MTOCs 
represented by the  tubulin staining (green), nuclear staining (blue) and a merged field. 
Representative images of the time course staining are shown.  
 
WT 26 hr 
WT 28 hr 
Mutant 34 hr 
Mutant 36 hr 
 tubulin Nuclear Merged Brightfield 
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of divided MTOCs and their migration along the nuclear envelope (Fig. 12). The 
identification of the involvement of PFRLP1 in nuclear division led to the investigation of the 
presence of PFRLP1 in parasite MTOCs.  Indirect immunofluorescence assays were used to 
evaluate the co-localization of PFRLP1 with the previously used MTOC protein, -tubulin. 
Microscopic analysis revealed that PFRLP1 co-localized with α-tubulin of the MTOCs 
during nuclear division, most prevalently during the early stages of nuclear division (Fig. 13). 
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Figure 12. Nuclear division time course analysis. The analysis of the time course samples of 
both strains over a 20 hour time period was conducted to determine the number of parasites 
with two MTOCs. The presence of two MTOCs was the indication of the beginning of 
nuclear division. The WT strain has a six hour advantage with significantly higher numbers 
of paired MTOCs (Means ± SD are indicated and a two-tailed unpaired t-test was used to 
determine significance, * = p  0.0005).    
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Figure 13. Panel of antiserum and α-tubulin staining of the three stages of intraerythrocytic 
cycle. A staining panel showing, from left to right; Hoechst staining the nuclei in blue, 
PFRLP1 antiserum in green, α-tubulin in red, and the merged images. The three stages of the 
intraerythrocytic cycle are shown by row from top to bottom; ring stage, early trophozoite, 
and schizont. 
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Discussion: 
Malaria is a deadly disease caused by the single celled protozoan parasite P. 
falciparum. There are more than 100 species of Plasmodium that infect a wide range of 
animal species. There are five strains that infect humans, the deadliest of which is P. 
falciparum. The lethal effects of malarial infection are caused by the intraerythrocytic cycle, 
known as the blood stage of infection (Fig. 2). During this stage the parasite rapidly 
multiplies inside of RBCs, creating pathology that results in cyclic fever, anemia, jaundice, 
splenomegaly, coma, and death (Akinosoglou et al. 2012, Chua et al. 2013). There are 
several pharmaceutical interventions available on the market to combat malaria; but the rise 
of strains resistant to these interventions has become a significant problem. To date, resistant 
strains have been identified for all current pharmaceutical treatments (Ecker et al. 2012, 
Talisuna et al. 2012, White and Pongtavornpinyo 2003). 
In order to gain a better understanding of this parasite, scientists around the world 
combined their efforts to sequence the genome of P. falciparum. It has been more than a 
decade since the genome was sequenced; currently, more than 50% of the genome is still 
annotated to code for genes of unknown function (Gardner et al. 2002). Typical reverse 
genetic screens have been cumbersome and ineffective due to the majority of the genome 
being comprised of genes with no significant homologues. The difficulty of inferring 
function from homologous genes is coupled with the difficulty of efficiently transfecting P. 
falciparum.  The development, and advancement, of forward genetic screens has increased 
the efficiency of genomic experimentation in modern research (Di Girolamo et al. 2005). 
Current research is directed towards identifying critical proteins utilized by P. falciparum to 
regulate the progression through its life cycle (Fu et al. 2007, Mahajan et al. 2008). These 
critical proteins are ideal targets for the development of anti-malarial drugs. 
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The proliferation of P. falciparum during the blood stage results in exponential 
growth of the parasite and a severe pathology in the host (Gerald et al. 2011). It is the 
proliferation stage that results in disease; subsequently making it the stage of greatest interest 
for identifying critical regulatory proteins. A forward genetic screen for an attenuated 
proliferation phenotype identified gene PF3D7_1143500 as a critical gene (Balu et al. 2010). 
Bioinformatics analysis of PF3D7_1143500 identified the presence of a nuclear localization 
signal and two repeats with a partial homology to the human RCC1 protein. RCC1 is known 
to play a pivotal role in regulating nuclear protein import and export in eukaryotes (Hadjebi 
et al. 2008). The identification of the partial homology to the RCC1 motif led to the labeling 
of this gene as P. falciparum RCC1-like protein 1, or PFRLP1. 
Examination of expression and localization during the intraerythrocytic cycle were 
essential before the role of PFRLP1 could be determined. Antibodies specific for PFRLP1 
were produced in order to characterize its expression pattern and localization. First, using 
EpiC online software, an amino acid sequence with a high antigenicity score and low 
homology to other P. falciparum proteins was identified. Codon optimization technology and 
an inducible vector construct from the company DNA 2.0 was used to create a plasmid for 
recombinant protein expression in E. coli. The amino acid sequence of interest was 
expressed, purified, and then inoculated into a rat host (Harlan Labs). The antiserum was 
tested for specificity to PFRLP1 and used to determine the expression pattern. PFRLP1 was 
found to be equally expressed over the three stages of the intraerythrocytic cycle. The 
PFRLP1 protein was found to localizing to the periphery of the nucleus.  
The intraerythrocytic cycle is a complex series of events that ultimately leads to 
exponential parasite growth. One parasite yields approximately 20 new merozoites during the 
48 hour intraerythrocytic cycle. The cycle is composed of three basic components; the initial 
invasion of RBCs, merozoite progression through the cell cycle, and egress from the RBC. A 
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mutant library of over two hundred strains was screened for reduced proliferation; PFRLP1 
was identified during this screen as a gene of interest (Balu et al. 2010). This screen for 
attenuated growth did not identify the cause for the reduction. To further isolate the cause of 
reduced proliferation a comparative analysis of the intraerythrocytic cycle was conducted. 
Any dysfunction within the intraerythrocytic cycle time could have severe impacts on 
proliferation. P. falciparum has been shown to be able to survive while modulating this cycle 
time (Babbitt et al. 2012). An example of this capacity occurs during isoleucine starvation. 
Under this condition P. falciparum has been shown to go into a hibern  atory state that can 
last for up to 72 hours and then successfully continue proliferating after re-supplementation 
of isoleucine. The lengthening of the cycle time for the PFRLP1 mutant could explain the 
observed attenuation of proliferation. Synchronized cultures were used for flow cytometry 
and microscopic analysis to determine the intraerythrocytic cycle time of the PFRLP1 
mutant. The analysis revealed no difference between cycle time of the wild type strain and 
the PFRLP1 mutant, indicating that the dysfunction in the PFRLP1 mutant proliferation was 
not due to an altered cycle time. 
 A proliferation assay was conducted and identified an attenuation of the PFRLP1 
mutant in vitro over an 8 day period in blood culture. A previous study examined RBC 
invasion and egress of the wild type and the PFRLP1 mutant but no differences were found 
(Data not shown; Balu et al., unpublished data). The findings of this study confirm previous 
data (Balu et al. 2010). These findings, along with the cycle time data, allowed the scope of 
the study to be narrowed to the intraerythrocytic cycle.  
 No differences were found in the different aspects of the intraerythrocytic cycle; 
cycle time, RBC egress, and RBC invasion. This led to closer examination of the 
intraerythrocytic cycle stages. The intraerythrocytic cycle is composed of three distinct 
stages; ring stage, trophozoite stage, and schizont stage. Schizogony is the act of asexual 
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reproduction by fission that leads to the multiple progeny during the intraerythrocytic cycle 
and the development of the mature schizont (Hafalla et al. 2011). Improper schizogony could 
have a drastic effect on proliferation and the progression from trophozoite to schizont.  
Schizogony is known to be regulated by various factors. One example of this is access to 
proper serum components can inhibit proper schizogony. Under conditions of deprived high 
density lipoprotein (HDL) the cell cycle of P. falciparum can be halted before schizogony 
(Grellier et al. 1990). Another factor known to effect schizogony is proper polypeptide 
substrates. Each stage is accompanied by specific polypeptide profiles that are essential for 
the progression of the intraerythrocytic cycle. Blood stage progression of P. falciparum can 
become impaired without the proper substrates for the synthesis of these crucial polypeptides. 
This sensitivity to the polypeptide substrates is indicative of the essential nature of certain 
proteins in proper proliferation (Boyle et al. 1983). Several aspects have been identified that 
affect schizogony but there is very little known about the regulation of the cell cycle in P. 
falciparum. There are many different aspects known to be crucial to the proper progression 
through the intraerythrocytic cycle; the role of epigenetics, the accessibility of genes during 
the subsequent stages, the function of protein profiles specific to each of these stages, and 
components of the host serum. Schizogony was examined in order to determine if the 
attenuation of proliferation was due to a stage specific impairment. This led to the 
examination of schizogony and mature schizont development. Triplicate cultures of WT and 
PFRLP1 mutant late stage schizonts were examined via microscopy and the number of 
merozoites formed during schizogony was counted. Purified late stage parasites in the 
PFRLP1 mutant showed schizonts with a 40% reduction in the number of merozoites being 
formed. This is the first insight into a possible cause for the difference found in the 
proliferation assay. 
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 The discovery of reduced numbers of merozoites formed during intraerythrocytic 
schizogony in the PFRLP1 mutant led to a conditional knockout study. The conditional 
knockout study was performed to verify that the restoration of PFRLP1 expression could 
restore the mutant phenotype to wild type levels. The conditional knockout comes with an 
‘on and off’ switch that allows the comparison of a single clone to itself under culture 
conditions (Balu 2012). A shield1 sensitive DD was inserted into the PFRLP1 gene for the 
conditional knockout study. The shield1 sensitive DD has been successfully used in P. 
falciparum studies, showing effective degradation without shield1 treatment and phenotypic 
rescue under shield1 treatment (Russo et al. 2009). The conditional knockout model in this 
study identified a reduction in merozoite formation when clones treated with shield1 were 
compared to untreated cultures. The untreated DD clones did not reduce the number of 
merozoites formed per schizont to levels as low as the original PFRLP1 mutant. However, 
under shield1 treatment, the number of merozoites formed per schizont did return to wild 
type levels. The DD targets the protein product for autolysis by the proteasome immediately 
after synthesis. The untreated DD mutants did not have a reduction in merozoite formation as 
great as the PFRLP1 knockout mutant. A possible explanation for this is incomplete protein 
degradation. For example, the proteasome may have not been able to degrade all of the 
PFRLP1 produced. The partial degradation led to a phenotype that was not as severe as the 
original mutant, but the levels were returned to normal under shield1 treatment, verifying that 
the phenotype of merozoite formation inhibition is dependent on the level of PFRLP1 
expression. 
The reduction in the number of merozoites being formed during schizogony, and the 
subsequent confirmation with the conditional knockout experiment, led to the investigation of 
the cell cycle. Plasmodium falciparum has an atypical mitotic cycle compared to other 
eukaryotes (Gerald et al. 2011). During eukaryotic mitosis the establishment of MTOCs at 
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polar opposites of the cell occurs before the separation of the duplicated genomes. Unlike 
mitosis in the typical eukaryote, Plasmodium begins to separate the genome before 
establishing poles (Fig. 14). As the parasite continues the mitotic phase of schizogony there 
are multiple genomes replicated within one nuclear membrane; and these can be in various 
stages of the mitotic cycle. Synchronized cultures of iRBCs were used in an 
immunohistochemistry assay with anti -tubulin antibodies to identify MTOC formation and 
duplication as a marker for the initiation of nuclear division. The result of the assay was a 
delay of 6-8 hours in the initiation of nuclear division in the PFRLP1 mutant. The delayed 
initiation of nuclear division, while maintaining a normal cycle time, explains the deficiency 
in the number of merozoites being formed during schizogony. 
The identification of a delay in the separation of MTOCs during nuclear division 
further led to the examination of the relationship between MTOCs and PFRLP1. An 
immunofluorescence assay was performed to determine the localization of PFRLP1 in 
respect to the MTOCs during nuclear division. The staining revealed that PFRLP1 localized 
to the MTOCs, inferring a role in regulating the proper function of MTOCs during nuclear 
division. 
A thorough understanding of the role that PFRLP1 plays in regulating merozoite 
formation and the initiation of mitosis will require further studies to identify the mechanism 
of its action. Immunoprecipitation assays would need to be performed to identify any protein 
partners that interact with PFRLP1.  Protein-interaction studies could help identify any 
biological pathways in which PFRLP1 plays a role, by examining partner protein functions 
and roles. Since the homologous motif shared between human eukaryotic RCC1 and PFRLP1 
is the chromatin-binding motif, chromatin-immunoprecipitation studies using PFRLP1 
antibodies could help identify any specific genes or sequences it interacts with in the parasite 
chromatin.  
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Figure 14. Comparison of mitosis between a typical eukaryotic cell and Plasmodium. The 
division of genomes in Plasmodium begins as the MTOCs begin to migrate along the nuclear 
membrane, while the typical eukaryote does not begin to separate the genomes until after 
migrating to the poles (Gerald et al. 2011). 
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This study has identified a novel protein in P. falciparum.  This protein plays a 
critical role in merozoite formation by regulating the initiation of nuclear division during 
mitosis. To date there are only two other proteins known to play a role in the regulation of 
mitosis in P. falciparum.  One protein is PfCEN1, which is a protein suspected to interact 
with the centrosome during nuclear division (Mahajan et al. 2008). This indicates the 
importance of proper nuclear division in the proliferation of P. falciparum. The second 
protein is an aurora-like kinase, an enzyme that regulates the proper progression of the cell 
cycle (Reininger et al. 2011). This regulation is achieved by the protein phosphorylating 
serine/threonine of specific targets essential for initiating the next stage of cellular division. 
This study has identified a third protein critical for the progression of P. falciparum through 
mitosis.  PFRLP1 is therefore a valuable exploratory target for antimalarial drug 
development, as it offers a crucial biological pathway to target in the intraerythrocytic cycle 
of Plasmodium. 
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